Bio-Rad Laboratories Inc (BIO)
281.97
+2.14
(+0.76%)
USD |
NYSE |
May 06, 16:00
281.74
-0.23
(-0.08%)
Pre-Market: 20:00
Bio-Rad Laboratories Price to Book Value: 0.9199 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 0.9199 |
| May 03, 2024 | 0.913 |
| May 02, 2024 | 0.9113 |
| May 01, 2024 | 0.8941 |
| April 30, 2024 | 0.8801 |
| April 29, 2024 | 0.9041 |
| April 26, 2024 | 0.9003 |
| April 25, 2024 | 0.8992 |
| April 24, 2024 | 0.9077 |
| April 23, 2024 | 0.9307 |
| April 22, 2024 | 0.9139 |
| April 19, 2024 | 0.9126 |
| April 18, 2024 | 0.9168 |
| April 17, 2024 | 0.9489 |
| April 16, 2024 | 0.9551 |
| April 15, 2024 | 0.9801 |
| April 12, 2024 | 0.9802 |
| April 11, 2024 | 1.018 |
| April 10, 2024 | 1.080 |
| April 09, 2024 | 1.108 |
| April 08, 2024 | 1.065 |
| April 05, 2024 | 1.059 |
| April 04, 2024 | 1.053 |
| April 03, 2024 | 1.071 |
| April 02, 2024 | 1.072 |
| Date | Value |
|---|---|
| April 01, 2024 | 1.106 |
| March 28, 2024 | 1.128 |
| March 27, 2024 | 1.140 |
| March 26, 2024 | 1.111 |
| March 25, 2024 | 1.113 |
| March 22, 2024 | 1.143 |
| March 21, 2024 | 1.148 |
| March 20, 2024 | 1.097 |
| March 19, 2024 | 1.098 |
| March 18, 2024 | 1.088 |
| March 15, 2024 | 1.088 |
| March 14, 2024 | 1.084 |
| March 13, 2024 | 1.098 |
| March 12, 2024 | 1.100 |
| March 11, 2024 | 1.123 |
| March 08, 2024 | 1.122 |
| March 07, 2024 | 1.107 |
| March 06, 2024 | 1.087 |
| March 05, 2024 | 1.080 |
| March 04, 2024 | 1.092 |
| March 01, 2024 | 1.084 |
| February 29, 2024 | 1.063 |
| February 28, 2024 | 1.078 |
| February 27, 2024 | 1.076 |
| February 26, 2024 | 1.103 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8801
Minimum
Apr 30 2024
2.323
Maximum
Jun 02 2020
1.613
Average
1.656
Median
Mar 31 2022
Price to Book Value Benchmarks
| Agilent Technologies Inc | 6.659 |
| Bruker Corp | 7.356 |
| Azenta Inc | 1.263 |
| Harvard Bioscience Inc | 2.328 |
| Bionano Genomics Inc | 0.6929 |
Price to Book Value Related Metrics
| PS Ratio | 3.090 |
| Price to Free Cash Flow | 37.82 |
| Price | 281.97 |
| Earnings Yield | -7.62% |
| Market Cap | 8.041B |
| Operating PE Ratio | 24.44 |
| Normalized PE Ratio | 26.50 |